LANZHOU做管理系统要多少钱, Sept. 11 (Xinhua) -- Bacterial therapy could offer a promising new method for the prevention and treatment of colorectal cancer, according to a study carried out by Chinese researchers.
The recent study conducted by the School of Life Sciences at Lanzhou University in northwest China's Gansu Province, has revealed that the probiotic limosilactobacillus fermentum GR-3, derived from "Jiangshui," a traditional fermented food in northwestern China, demonstrates potential for promoting apoptosis in colon tumor cells and inhibiting their proliferation.
Professor Li Xiangkai, head of the research group and a professor at the university's School of Life Sciences, explained that studies have shown that colorectal cancer patients often experience an imbalance in their gut microbiota and a persistent state of peroxidation in tumor cells. Unlike conventional antioxidants, probiotics like Lactobacillus GR-3 could specifically target the tumor microenvironment while also regulating intestinal flora.
软件开发Li's team successfully isolated Lactobacillus GR-3, a strain with strong antioxidant properties. In both hyperuricemia mouse models and clinical trials, this strain has shown promise in promoting uric acid degradation by modulating the gut microbiome. Building on these findings, the research team explored the potential of Lactobacillus GR-3 in preventing colorectal cancer through its effects on gut flora and the host immune system.
张单鸿：足球预测又斩14连红，欧洲杯期间状态火热，此前还曾8连红、9连红、11连红，长线战绩命中率超高！欧洲杯半决赛西法大战又红，荷兰vs英格兰稳胆已出！[查看今日推荐]
距离夏窗关闭只剩最后5天时间，泰山队此前已经将宋龙、吉翔和韩镕泽3名球员租借到其他球队，管理系统开发价格史松宸被撤销报名驰援B队，不过迟迟没有“进人”，卡约和何小珂仍在试训阶段，泽卡将于本月20日归队，不过目前还没有报名，泰山队仍是只出不进状态。
The results showed that Lactobacillus GR-3 significantly reduced the growth of colon tumors in drug-induced mice and demonstrated positive therapeutic effects. The strain not only lowered tumor mass but also improved the composition of intestinal microbial metabolites, promoted apoptosis in colon cancer cells, and inhibited their proliferation.
The research team will conduct further studies to investigate the specific mechanisms of action of Lactobacillus GR-3 and evaluate its clinical efficacy.
Colorectal cancer is one of the most common cancers in China. While existing research primarily focuses on how probiotics regulate the host immune system, there has been comparatively little exploration of their antioxidant properties and ability to modulate gut microbiota.
"Our study aims to identify probiotics with strong antioxidant capacity and robust gut flora regulatory effects做管理系统要多少钱, providing new insights into the prevention and inhibition of colorectal cancer," said Li. ■